[ Back to EurekAlert! ]

Contact: Axel Storz
axel.storz@ipa.fraunhofer.de
49-711-970-3660
Fraunhofer-Gesellschaft

A Cost-Effective Way toward Personalized Cancer Drugs

Caption: The process starts with the automated, mechanical disruption of the tissue sample.

Credit: Fraunhofer IPA

Usage Restrictions: The picture may be used for editorial purposes only. It is protected by copyright. The use is free of charge if the reference is mentioned.

Related news release: A cost-effective way toward personalized cancer drugs


[ Back to EurekAlert! ]